- Home
- LVRO vs PCRX Comparison
LVRO vs PCRX Comparison
Compare LVRO & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- PCRX
- Stock Information
- Founded
- LVRO 2017
- PCRX 2006
- Country
- LVRO Brazil
- PCRX United States
- Employees
- LVRO N/A
- PCRX N/A
- Industry
- LVRO Blank Checks
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- LVRO Finance
- PCRX Health Care
- Exchange
- LVRO Nasdaq
- PCRX Nasdaq
- Market Cap
- LVRO 279.6M
- PCRX 1.2B
- IPO Year
- LVRO N/A
- PCRX 2011
- Fundamental
- Price
- LVRO $2.24
- PCRX $23.22
- Analyst Decision
- LVRO Sell
- PCRX Buy
- Analyst Count
- LVRO 3
- PCRX 8
- Target Price
- LVRO $1.88
- PCRX $28.38
- AVG Volume (30 Days)
- LVRO 8.8K
- PCRX 569.8K
- Earning Date
- LVRO 07-11-2025
- PCRX 07-29-2025
- Dividend Yield
- LVRO N/A
- PCRX N/A
- EPS Growth
- LVRO N/A
- PCRX N/A
- EPS
- LVRO N/A
- PCRX N/A
- Revenue
- LVRO $1,667,345,189.00
- PCRX $702,772,000.00
- Revenue This Year
- LVRO N/A
- PCRX $7.54
- Revenue Next Year
- LVRO $12.46
- PCRX $10.78
- P/E Ratio
- LVRO N/A
- PCRX N/A
- Revenue Growth
- LVRO N/A
- PCRX 3.08
- 52 Week Low
- LVRO $1.90
- PCRX $11.16
- 52 Week High
- LVRO $5.69
- PCRX $27.64
- Technical
- Relative Strength Index (RSI)
- LVRO 43.94
- PCRX 35.42
- Support Level
- LVRO $1.95
- PCRX $22.82
- Resistance Level
- LVRO $2.22
- PCRX $24.36
- Average True Range (ATR)
- LVRO 0.20
- PCRX 0.69
- MACD
- LVRO -0.01
- PCRX -0.12
- Stochastic Oscillator
- LVRO 31.25
- PCRX 17.09
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.